CD3+ | CD3+CD8+ | CD3+CD8− | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
C | SpA | C | SpA | C | SpA | ||||||
IELs | n=10 | n=19 | n=8 | n=17 | n=8 | n=17 | |||||
IFNγ | 29 (15–65) | 26 (9–45) | 42 (18–77) | 40 (14–67) | 19 (9–38) | 20 (7–30) | |||||
IL2 | 43 (16–66) | 43 (17–67) | 37 (12–85) | 44 (11–73) | 47 (20–58) | 41 (20–61) | |||||
IL4 | 1.1 (0.2–3.6) | 0.9 (0.2–2.7) | 0.9 (0.1–2.7) | 0.9 (0.4–2.6) | 1.1 (0–4.4) | 1 (0.1–2.8) | |||||
IL10 | 2.9 (0.1–4.8) | 3 (1.4–5.7) | 2.2 (0.1–4.2) | 2.1 (1.1–6.1) | 4.2 (0.1–5.9) | 3.5 (1.4–7.5) | |||||
LPLs | n=10 | n=18 | n=9 | n=18 | n=9 | n=18 | |||||
IFNγ | 64 (42–72) | 54 (19–73)2-150 | 78 (53–88) | 67 (30–84) | 57 (37–67) | 47 (15–70)2-150 | |||||
IL2 | 71 (49–85) | 67 (21–74) | 60 (38–87) | 60 (15–81) | 74 (47–84) | 67 (21–78)2-150 | |||||
IL4 | 1.8 (0.9–4.2) | 1.7 (0.4–5.3) | 3.4 (0.7–6.5) | 2.9 (0.6–16) | 1.4 (0.5–3.2) | 1.3 (0–5.3) | |||||
IL10 | 3 (1.4–7.3) | 3.7 (1.9–6.8) | 3 (1.1–7.9) | 4.2 (1.8–10.2) | 2.6 (1.5–6.9) | 3.3 (0.5–7) |
Results are expressed as the median (range).
↵2-150 p<0.05 compared with controls.
IFN = interferon; IL = interleukin; IEL = intraepithelial lymphocyte; LPL = lamina propria lymphocyte; PMA = phorbol 12-myristate 13-acetate.